LGVN Research and Charts

LGVN - Longeveron Inc Ordinary Shares - Class A (Healthcare: Biotechnology)

Projected Earnings Date: 0000-02-29 (Delayed quote data 2025-04-04)

Last 1.40	Change ⇓ -0.05 (-3.45%)	Volume 142,979
	Open 1.41	High 1.43	Low 1.30

8EMA (Daily) 1.54	40EMA (Daily) 1.61	50EMA (Daily) 1.63	STO (Daily) 15.726	MACD Hist (Daily) -0.070
8EMA (Weekly) 1.596	40EMA (Weekly) 1.83	50EMA (Weekly) 1.88	STO (Weekly) 37.228	MACD Hist (Weekly) -0.015


Company Profile
Longeveron Inc is a biotechnology company developing cellular therapies for specific ageing-related and life-threatening conditions. It is involved in sponsoring clinical trials in the following indications: Aging Frailty, Alzheimer's disease, the Metabolic Syndrome, Acute Respiratory Distress Syndrome (ARDS), and Hypoplastic left heart syndrome (HLHS).

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.